CIK cells have demonstrated antitumor activity in research settings, yet persistence, tumor specificity, and microenvironmental suppression can limit performance. Genetic engineering and CAR-CIK strategies provide research strategies for investigating these barriers.
Cytokine-induced killer (CIK) cells have attracted interest in cancer immunotherapy because they combine T-cell and...
